Life Sciences MVP: Paul Weiss' Nicholas Groombridge
Law360, New York (November 25, 2015, 1:15 PM EST) -- Nicholas P. Groombridge of Paul Weiss Rifkind Wharton & Garrison LLP argued a monumental biosimilars case at the Federal Circuit and secured a historic victory for Amgen and the entire industry of brand-name biologics, placing him among Law360's Life Sciences MVPs of 2015.
The July triumph in Amgen Inc. v. Sandoz Inc. centered on a landmark interpretation of the Affordable Care Act's biosimilars pathway, known as the Biologics Price Competition and Innovation Act.
Groombridge delivered oral arguments for Amgen at the Federal Circuit, which partly reversed a district judge who had sided entirely with Sandoz....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!